Gland Pharma Limited has announced a schedule of upcoming meetings with analysts and institutional investors. These meetings are slated to take place from June 9 to June 11, 2026. The company will engage in one-on-one meetings with various investors and analysts. Specifically, on June 9, 2026, Gland Pharma is scheduled to meet with Haitong Securities and an NDR arranged by ICICI Securities. Further meetings are planned for June 10, 2026, with Midas Research, and on June 11, 2026, with Sohum Asset. The company has noted that this schedule is subject to change due to unforeseen circumstances on the part of the investors, analysts, or the company itself. This intimation is provided in compliance with Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
